Diagnosis Code

Z79.622 LONG TERM (CURRENT) USE OF JANUS KINASE INHIBITOR


Code Information

Diagnosis Code: Z79.622

Short Description: Long term (current) use of Janus kinase inhibitor

Long Description: Long term (current) use of Janus kinase inhibitor

The code Z79.622 is VALID for claim submission

Code Classification:

  • Factors influencing health status and contact with health services (Z00–Z99)
    • Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
      • Long term (current) drug therapy (Z79)
        • Z79.622 Long term (current) use of Janus kinase inhibitor

This code is valid for unacceptable principal diagnosis

Code Version: 2022 ICD-10-CM


Diagnostic Related Group(s)

The code Z79.622 is grouped in the following Diagnostic Related Group(s) (MS-DRG v39.0)
  • Aftercare With Cc/mcc (949)
  • Aftercare Without Cc/mcc (950)

References to Index of Diseases and Injuries

The code Z79.622 has the following ICD-10-CM references to the Index of Diseases and Injuries
  • Inclusion Terms:
    • Long term (current) use of tofacitinib

Similar Codes

ICD-10 Code ICD-10 Description
Z79 Long term (current) drug therapy
Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets
Z79.01 Long term (current) use of anticoagulants
Z79.02 Long term (current) use of antithrombotics/antiplatelets
Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID)
Z79.2 Long term (current) use of antibiotics
Z79.3 Long term (current) use of hormonal contraceptives
Z79.4 Long term (current) use of insulin
Z79.5 Long term (current) use of steroids
Z79.51 Long term (current) use of inhaled steroids
Z79.52 Long term (current) use of systemic steroids
Z79.6 Long term (current) use of immunomodulators and immunosuppressants
Z79.60 Long term (current) use of unspecified immunomodulators and immunosuppressants
Z79.61 Long term (current) use of immunomodulator
Z79.62 Long term (current) use of immunosuppressant
Z79.620 Long term (current) use of immunosuppressive biologic
Z79.621 Long term (current) use of calcineurin inhibitor
Z79.623 Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
Z79.624 Long term (current) use of inhibitors of nucleotide synthesis
Z79.63 Long term (current) use of chemotherapeutic agent
Z79.630 Long term (current) use of alkylating agent
Z79.631 Long term (current) use of antimetabolite agent
Z79.632 Long term (current) use of antitumor antibiotic
Z79.633 Long term (current) use of mitotic inhibitor
Z79.634 Long term (current) use of topoisomerase inhibitor
Z79.64 Long term (current) use of myelosuppressive agent
Z79.69 Long term (current) use of other immunomodulators and immunosuppressants
Z79.8 Other long term (current) drug therapy
Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels
Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
Z79.811 Long term (current) use of aromatase inhibitors
Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Z79.82 Long term (current) use of aspirin
Z79.83 Long term (current) use of bisphosphonates
Z79.84 Long term (current) use of oral hypoglycemic drugs
Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs
Z79.89 Other long term (current) drug therapy
Z79.890 Hormone replacement therapy
Z79.891 Long term (current) use of opiate analgesic
Z79.899 Other long term (current) drug therapy


This page was last updated on: 10/1/2023